Mirabegron – a selective β3-adrenoreceptor agonist for the treatment of overactive bladder

Overactive bladder is a common condition that significantly impacts overall quality of life. Antimuscarinics are the current main pharmacological option for treatment; however, many patients fail to adhere to therapy due to troublesome side effects. Mirabegron is a new beta-3 adrenoreceptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhide, Alka A, Digesu, G Alessandro, Fernando, Ruwan, Khullar, Vik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806442/
https://www.ncbi.nlm.nih.gov/pubmed/24199179
http://dx.doi.org/10.2147/RRU.S28930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806442/
https://www.ncbi.nlm.nih.gov/pubmed/24199179
http://dx.doi.org/10.2147/RRU.S28930

Ejemplares similares